Predict your next investment

INTERNET | eCommerce / Auction & Classifieds
biddingforgood.com

See what CB Insights has to offer

Executives

7

Board of Directors

2

BiddingForGood Board of Directors

2 Board of directors

BiddingForGood has 2 board of directors, including Stephanie O'Brien.

Name

Firm

Work History

Other Seats

Stephanie O'Brien

Stephanie O’Brien has been a member of the Morningside investment team since 1997, working with venture-backed companies focused on novel science. Ms. O’Brien has been a director of numerous companies developing drugs across a broad spectrum of therapeutic areas, including oncology and immunotherapy, and has extensive experience providing operational and management guidance to rapidly growing life science and technology companies. She has served on public and private company boards, including Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Aduro Biotech, Inc.(NASDAQ:ADRO), I-Behavior, Inc., Canopy Education, Inc., Natural Polymer International Corp., Linc Global, Inc., Vioptix, Inc., and Vigeo Therapeutics, Inc. Ms. O’Brien has also worked on M&A deals and financings for public and private companies such as DNAtrix, Inc., Dendreon Corporation, BioVex Group, Inc., Stealth Biotherapeutics Inc. and Sohu.com. Prior to Morningside, Ms. O’Brien spent nine years as a corporate lawyer with Hale and Dorr in the Boston and Washington, D.C. offices, working primarily with venture capital finance and start-up companies. She received her A.B., cum laude, from Harvard College and her J.D. from New York University School of Law.

BiddingForGood

Stephen Green

BiddingForGood

Name

Stephanie O'Brien

Stephen Green

Firm

Work History

Stephanie O’Brien has been a member of the Morningside investment team since 1997, working with venture-backed companies focused on novel science. Ms. O’Brien has been a director of numerous companies developing drugs across a broad spectrum of therapeutic areas, including oncology and immunotherapy, and has extensive experience providing operational and management guidance to rapidly growing life science and technology companies. She has served on public and private company boards, including Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Aduro Biotech, Inc.(NASDAQ:ADRO), I-Behavior, Inc., Canopy Education, Inc., Natural Polymer International Corp., Linc Global, Inc., Vioptix, Inc., and Vigeo Therapeutics, Inc. Ms. O’Brien has also worked on M&A deals and financings for public and private companies such as DNAtrix, Inc., Dendreon Corporation, BioVex Group, Inc., Stealth Biotherapeutics Inc. and Sohu.com. Prior to Morningside, Ms. O’Brien spent nine years as a corporate lawyer with Hale and Dorr in the Boston and Washington, D.C. offices, working primarily with venture capital finance and start-up companies. She received her A.B., cum laude, from Harvard College and her J.D. from New York University School of Law.

Other Seats

BiddingForGood

BiddingForGood

BiddingForGood Management Team

7 Team Members

BiddingForGood has 7 executives. BiddingForGood's current Chief Financial Officer is Harris A Fishman.

Name

Work History

Title

Status

Harris A Fishman

Chief Financial Officer

Current

Jonathan Carson

Chief Executive Officer

Former

Nina Vellayan

Chief Executive Officer, President

Former

Hutch Fishman

Chief Financial Officer

Former

Todd Rodgers

Chief Technology Officer

Former

Name

Harris A Fishman

Jonathan Carson

Nina Vellayan

Hutch Fishman

Todd Rodgers

Work History

Title

Chief Financial Officer

Chief Executive Officer

Chief Executive Officer, President

Chief Financial Officer

Chief Technology Officer

Status

Current

Former

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.